GREY:TSTIF - Post by User
Comment by
BernardBaruch60on Jul 19, 2019 9:01am
115 Views
Post# 29938895
RE:RE:RE:RE:Same Bash Over and Over
RE:RE:RE:RE:Same Bash Over and OverAgain, Cash is lying.
VP4 is not the lowest cost low-temp sterilizer and not by a long shot. They're the only company to give their sterilizers away for free in a raffle. So, yes when they give it away for free, it's the lowest cost, but shows the reality of their desperation.
TSO3 marketed to hospitals they have Duodenoscope Clearance from FDA. They DO NOT!! Believe me, as a former SPD manager- nothing will upset potential SPD managers more than being hoodwinked!!
On Dec 18, 2017- Olympus, by far the market leader in endoscopes, issues a Safety Alert/Statement specifically calling out the VP4's non-compatibility with Olympus scopes. 2 months after this letter, the stock freefalls. Coincidence??
Who has made money on this company? Why haven't hospitals adopted this so called exceptional technology?? Why does Cash keep lying???
I invested knowing it would be a gamble given the company's financials, but I too believed they had a Duodenoscope Clearance and thought there would be no way to capitalize in a market I'm investing in. I should have performed more research on this management and the particular technology.
To hear Cash's repeated BS on this board as people lose money not only makes my blood boil, but has taught me an important financial lesson. As a former industry decision maker who understands and plays in a market I understand, I now realize market potential does not supercede a company's leadership and financials.